These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in heart transplant recipients. Teebken OE; Strüber M; Harringer W; Pichlmaier MA; Haverich A Transplant Proc; 2002 Jun; 34(4):1265-8. PubMed ID: 12072335 [No Abstract] [Full Text] [Related]
4. Clinical outcomes associated with conversion to tacrolimus-based immunosuppression in pediatric cardiac transplantation. Walker RE; McCrindle BW; Coles JG; West LJ Transplant Proc; 1998 Jun; 30(4):1116-7. PubMed ID: 9636452 [No Abstract] [Full Text] [Related]
5. Twelve years of cyclosporine in pediatric heart transplantation: what is the future? Parisi F; Abbattista AD; Squitieri C; Vinciguerra G; La Vigna G; Di Donato R; Catena G Transplant Proc; 1998 Aug; 30(5):1967-8. PubMed ID: 9723355 [No Abstract] [Full Text] [Related]
6. Improved survival after lung transplantation in patients treated with tacrolimus/mycophenolate mofetil as compared with cyclosporine/azathioprine. Izbicki G; Shitrit D; Aravot D; Sulkes J; Saute M; Sahar G; Kramer MR Transplant Proc; 2002 Dec; 34(8):3258-9. PubMed ID: 12493439 [No Abstract] [Full Text] [Related]
8. Long-term persistence of lung function abnormalities after heart transplantation. Ewert R; Walde T; Bettmann M; Wensel R; Bauer U; Kleber FX; Hetzer R Transplant Proc; 1998 Aug; 30(5):1889-91. PubMed ID: 9723322 [No Abstract] [Full Text] [Related]
9. Effects of tacrolimus and cyclosporine on the coronary microcirculation after heart transplantation: a prospective study with serial intracoronary flow measurements. Rieber J; Klauss V; König A; Henneke KH; Spes C; Regar E; Werner F; Meiser B; Reichart B; Theisen K; Mudra H Transplant Proc; 1998 Jun; 30(4):1098-9. PubMed ID: 9636446 [No Abstract] [Full Text] [Related]
10. Immunosuppression switch in pediatric heart transplant recipients: cyclosporine to FK 506. Swenson JM; Fricker FJ; Armitage JM J Am Coll Cardiol; 1995 Apr; 25(5):1183-8. PubMed ID: 7534779 [TBL] [Abstract][Full Text] [Related]
11. Modern application for an old compound: 8-methoxypsoralen for photochemotherapy after heart transplantation. Meiser BM; Kur F; Uberfuhr P; Reichenspurner H; Kreuzer E; Reichart B Transplant Proc; 1993 Dec; 25(6):3307-8. PubMed ID: 8266554 [No Abstract] [Full Text] [Related]
13. Coronary endothelial vasomotor function and vascular remodeling in heart transplant recipients randomized for tacrolimus or cyclosporine immunosuppression. Petrakopoulou P; Anthopoulou L; Muscholl M; Klauss V; von Scheidt W; Uberfuhr P; Meiser BM; Reichart B; Weis M J Am Coll Cardiol; 2006 Apr; 47(8):1622-9. PubMed ID: 16631000 [TBL] [Abstract][Full Text] [Related]
14. Histopathological findings in heart transplant patients under tacrolimus-mycophenolate mofetil versus cyclosporine microemulsion-azathioprine. Sgrosso JL; Ferrer J; Araujo G; Romeo L; Parisi C; Vázquez MC Transplant Proc; 2002 Feb; 34(1):115-6. PubMed ID: 11959214 [No Abstract] [Full Text] [Related]
15. Clinical trial of FK506 in heart transplant patients in Taiwan: report of 7 cases with immunosuppression switch from cyclosporine to FK506. Ko WJ; Chou NK; Chen YS; Hsu RB; Wang SS; Chu SH Transplant Proc; 1998 Nov; 30(7):3339-41. PubMed ID: 9838474 [No Abstract] [Full Text] [Related]
16. Medium-term outcome of tacrolimus immunosuppression following rejection or graft dysfunction in heart transplant patients. Marcus N; Khaghani A; Burke M; Yacoub M; Banner N Transplant Proc; 1998 Jun; 30(4):1134-5. PubMed ID: 9636460 [No Abstract] [Full Text] [Related]